Vascular Grafts Market Size, Share, and Trends 2025 to 2034

What is the Vascular Grafts Market Size?

The global vascular grafts market size is calculated at USD 6.29 billion in 2025 and is predicted to reach around USD 9.88 billion by 2034, growing at a CAGR of 5.15% from 2025 to 2034.

Vascular Grafts Market Key Takeaways

• North America led the global market with the highest market share of 34% in 2024.
• By product, the endovascular stent grafts segment has held the largest market share of 65% in 2024.
• By application, the cardiac aneurysm segment captured the biggest revenue share of 52% in 2024.
• By raw materials, the polytetrafluoroethylene segment registered a maximum market share of 48% in 2024.

AI in the Market

AI is revolutionizing the market for vascular grafts through its application in various processes that include manufacturing, patient-specific grafts, and pre-surgical planning. The use of artificial intelligence allows the customization of grafts for specific patients, automates production to ensure consistency, and improves the accuracy of the development process through insights from imaging. Moreover, AI helps in the selection of the graft that is most compatible with the patient and aids in the monitoring of the patient’s condition after the operation in real-time. Also, it reduces the time required for the development of new products and provides data-based feedback that is useful for continuous improvement, thereby resulting in safer, more effective, and personalized vascular grafts.

Market Size and Forecast

• Market Size in 2024: USD 5.98 Billion
• Market Size in 2025: USD 6.29 Billion
• Forecasted Market Size by 2034: USD 9.88 Billion
• CAGR (2025-2034): 5.15%
• Largest Market in 2024: North America
• Fastest Growing Market: Asia Pacific

Vascular Grafts Market Growth Factors

The increase in the number of chronic kidney diseases and dialysis procedure has led to a growth in the market about a couple of million people take treatment for dialysis across the world so it happens to drive the market for vascular grafts. Increase in the cardiovascular diseases renal diseases and diabetes are driving the market for the vascular grafts. Across the world many deaths occur due to the cardiovascular diseases across many nations. Surgeries related to the heart involve the use of vascular grafts and hence the market is expected to grow during the forecast. The availability of reimbursement policies rising healthcare expenditure and increased demand for the technologically advanced products are offering great opportunities for the growth of this market the use of next generation tissue engineered vascular grafts is also driving the market across the globe. As there is an advancement in the surgical procedure related to the coronary artery the demand for vascular grafts is expected to grow in the coming years.

• The ascending occurrence of chronic diseases: The pumps of vascular grafts are getting stronger due to the ever-increasing numbers of patients with heart diseases, kidney disorders, and diabetes.
• Growing surgical practice numbers: The demand for vascular grafts is directly implicated in the increase in bypass and dialysis surgeries.
• Technology innovation: The technical creation of next-generation tissue-engineered and hybrid grafts with superior durability and biocompatibility has been the main driving force behind the expansion of the market.
• Supportive health care regulations: Better access to advanced surgical solutions due to the expanding reimbursement coverage and increasing healthcare investments.
• New surgical techniques: The raising of standards for the performance of vascular grafts is being induced by innovations in less invasive and coronary surgery methods.

Market Scope

Product Insights

On the basis of the product, the endovascular stent grafts segment accounted market share of around 65% in 2024. There is an increased growth specially in the treatment of abdominal aortic aneurysm and the increase in these treatments has led to a growth in the market. Increasing demand for thoracic aortic aneurysms has led to the adoption of endovascular stent grafts and this should be a major factor which shall help in the growth of the market. Stent graphs along with the antibiotics can be used in the treatment of mycotic aneurysm. The developments in the endovascular applications will lead to a growth in the endovascular stent grafts market. There is a fast rate of recovery with the use of endovascular grafts also there is a reduction in the hospital stay. Endovascular grafts are less painful when they are compared with the open surgeries so, there is an increasing demand for surgeries across the world.

Peripheral vascular grafts segment is also expected to have a good growth during the forecast. Due to increasing rate of hardening of the arteries and the conditions of renal failure and in order to treat the peripheral artery disease many technical advancements are made and products are developed that would lead to an increase in the demand of this segment in the forecast period.

Application Insights

The cardiac aneurysm segment accounted largest revenue share of around 52% in 2024. As there is an increase in various conditions like high blood pressure rising cholesterol levels the sedentary life style and the growing geriatric population across the globe the cardiac aneurysm segment will grow during the forecast. This segment is expected to grow in the future as the congenital heart disease involves congenital heart surgeries which are carried out using the advanced tissue engineered grafts is in demand. As a result high rate of organ transplant failure there is an increase in the adoption of minimally invasive vascular implants for the surgical reconstruction of cardiovascular diseases.

The demand for cardiac aneurysm products shall grow during the forecast period owing to all of these reasons. As there is unavailability of using grafts in vascular activation disease the demand for vascular occlusion shall help in the growth of the market in this segment. The synthetic grafts which are used in the treatment of vascular occlusion shall help in the growth of the market during the forecast.

Raw Materials Insights

On the basis of the raw material, the polytetrafluoroethylene segment accounted revenue share of 48% in 2024. Polytetrafluoroethylene is used for peripheral bypass procedures as this material adequately interacts with the tissue and it is extremely easy to use. Various technological advancements or modifications in this raw material have also helped in the growth of the market segment.

Apart from the polytetrafluoroethylene segment the polyester segment is also expected to have a significant growth during the forecast. As this material is easily available and it is robust and durable the market is expected to see a growth. The use of polyester vascular grafts has Increased as there is a demand for vascular grafts with small diameters. Therefore this market segment is expected to grow well during the forecast.

Regional Insights

U.S. Vascular Grafts Market Size and Growth 2025 to 2034

The U.S. vascular grafts market size was valued at USD 1.50 billion in 2025 and is expected to be worth around USD 2.37 billion by 2034, at a CAGR of 5.18% from 2025 to 2034.

North America is the largest market share 34% in 2024 for vascular grafts estrogen increasing health awareness and great health care facilities available across the nations, availability of good health care facilities for the treatment of cardiovascular diseases in this region has helped in the growth of the market adoption of advanced technological procedures and the availability of reimbursement policies have led to the growth in the market. As there is an increase in the development and discoveries of the tissue engineered products which are used in surgeries the market is growing. Constant R&D for the development of biomaterial grafts is providing a great opportunity for the growth of this market. People fear cardiac disorders as there are premature deaths hence the market is expected to grow well during the forecast period. Asia Pacific region is expected to witness strong growth over the forecast period 2025 to 2034.

How is North America leading in the Vascular Grafts Market?

North America is the leading continent in the vascular grafts market, which can be attributed to the availability of state-of-the-art healthcare systems, high public awareness, and a large amount of money spent on cardiac treatments. Furthermore, the rising prevalence of chronic illnesses, along with the general acceptance of the latest graft technologies, encourages growth in the region. Good insurance and access to qualified healthcare personnel are also ways in which they are erasing the barriers to market development.

United States Vascular Grafts Market Trends:

The U.S. is the driving force behind the vascular grafts market by becoming the foremost player in the geographical area, owing to its well-established healthcare system and its priority on the treatment of heart diseases. The comprehensive medical sector provides the essential conditions for a continuous supply of new tools, high patient awareness, and availability of advanced graft options, all contributing to the market's positive outlook. In addition, there is a steady flow of innovation supported by the synergy between academia and the manufacturing sector for research purposes.

What are the driving factors of the Vascular Grafts Market in Europe?

Europe is characterized as a well-established market for vascular grafts, where the growth is mainly driven by the rising healthcare investments and widely accepted medical technology. The market for non-invasive procedures that do not involve the use of synthetic grafts is continuously widening and becoming a real challenge for surgical solutions, especially in the face of obstructed coronary and peripheral vascular diseases. Cross-country differences in access to healthcare and reimbursement policies affect the uptake of different products in correlation with the access levels.

Germany Vascular Grafts Market Trends:

Germany has the largest market in Europe, thanks to its excellent healthcare facilities and considerable adoption of cutting-edge vascular repair devices. The country’s emphasis on precision medicine and clinical research is the main reason for the high-performance grafts. Moreover, the rise in the number of cardiac cases is the main factor that is leading the market to grow continuously.

How is Asia-Pacific performing in the Vascular Grafts Market?

Asia-Pacific is the region with the highest growth rate in the world, owing to its upgraded healthcare systems, increasing elderly population, and the rise in the number of patients with cardiovascular and renal diseases. Increased awareness, government support, and technology innovations in surgical care are the factors behind the positive trend in the regional market. The trend of adopting advanced graft technologies in the region is also a contributing factor to the long-term market growth.

China Vascular Grafts Market Trends:

Rapid growth is happening in the vascular graft market of China due to faster access to healthcare and the growing number of older people. The rising rates of vascular and heart disorders, and the government’s call for investments in medical infrastructure, are pushing the demand even further. The development of local production capabilities and breakthroughs in graft technology are also working to the advantage of market growth.

Vascular Grafts Market Companies

• Getinge AB
• Medtronic PLC
• LeMaitre vascular Inc
• WL gore and associates
• terumo corporation
• Shanghai suokang medical implants Co limited
• Cook medical

Recent Developments

• In March 2021 a medical device received approval from the FDA which is the Zenith fenestrated endovascular graft. This product is expected to provide great revenue from its sales as it will be effective in the treatment and the diagnosis of debilitating diseases or conditions.
• Terumo Aortic received approval for the Tero abdominal aortic stent grafts in October 2021. This Japanese device will be helped in the treatment for abdominal aortic aneurysms
• The relay pro thoracic stent grafts system was also approved by FDA in August 2021 the terumo corporation will use this for the treatment of patients with a thoracic aortic aneurysms.
• ArtegraftInc was acquired by LeMaitre Vascular Inc in June 2020. This acquisition helped in gaining access to the ArtegraftInc’s portfolio of biological vascular grafts.
• In February 2025, Humacyte launched Symvess, an acellular tissue-engineered vessel, for urgent revascularization in adults with extremity arterial injuries when autologous vein grafts aren't possible.
  https://vascularnews.com
• In November 2024, Solaris Endovascular, based in New Orleans, focuses on dialysis access and peripheral artery disease solutions, developing technologies to enhance fistulae, grafts, and arteries' patency, improving patient health, and reducing costs.
  https://www.massdevice.com

Value Chain Analysis

• R&D: Creating and examining new biomaterials and techniques that can lead to vascular grafts with excellent biocompatibility and longevity.
  Key Players: Medtronic, W. L. Gore & Associates, LeMaitre Vascular
• Clinical Trials and Regulatory Approvals: Carrying out studies under controlled conditions to prove the product's safety and effectiveness and get approval from regulatory bodies.
  Key Players: Terumo Corporation, Medtronic, Cook Medical, various Contract Research Organizations (CROs)
• Formulation and Final Dosage Preparation: The process of grafts being made, put together, sterilized, and being ready for surgical implantation.
  Key Players: W. L. Gore & Associates, LeMaitre Vascular, Medtronic
• Packaging and Serialization: The use of packaging that is free from germs and the assigning of unique serial numbers for product traceability and authenticity.
  Key players: Amcor, Gerresheimer, Schott AG, and Becton Dickinson
• Distribution to Hospitals, Pharmacies: The management of logistics that are both safe and efficient to get grafts to healthcare facilities and storage.
  Key players: Medtronic, Cardinal Health, Cook Medical
• Patient Support and Services: After-sales support, training for clinicians, and monitoring post-implantation are some of the activities undertaken to ensure patient safety and efficacy of the product.
  Key Players: Hospitals, specialty clinics, Medtronic, Terumo

Segments covered in the report

By Product

• Vascular Grafts for Aorta Disease
• Peripheral Vascular Grafts
• Endovascular Stent Grafts
• Coronary Artery By-Pass Grafts

By Application

• Cardiac Aneurysm
• Kidney Failure
• Vascular Occlusion
• Coronary Artery Disease

By Raw Material

• Polyester Vascular Grafts
• Polytetrafluoroethylene Vascular Grafts
• Polyurethane Vascular Grafts
• Biological Material Based Vascular Grafts
• Human Saphenous and Umbilical Veins
• Tissue Engineered Materials

By End User

• Hospitals
• Ambulatory Surgical Centers

By Geography

• North America
• U.S.
• Canada
• Europe
• U.K.
• Germany
• France
• Asia-Pacific
• China
• India
• Japan
• South Korea
• Malaysia
• Philippines
• Latin America
• Brazil
• Rest of Latin America
• Middle East & Africa (MEA)
• GCC
• North Africa
• South Africa
• Rest of the Middle East & Africa